John P. Hamill Aprea Therapeutics, Inc. (APRE) insider trading activity

APRE Quotes by TradingView

John P. Hamill is SrVP/CFO/Prin Fin & Acct Ofcr of Aprea Therapeutics, Inc.. Currently has a direct ownership of 19,368 shares of APRE, which is worth approximately $56,554. The most recent transaction as insider was on Oct 11, 2024, when has been sold 50 shares (Common Stock) at a price of $2.46 per share, resulting in proceeds of $123. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.4K
2.65% 3M change
33.64% 12M change
Total Value Held $56,554

John P. Hamill Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 11 2024
BUY
Open market or private purchase
$123 $2.46 p/Share
50 Added 0.26%
19,368 Common Stock
Oct 10 2024
BUY
Open market or private purchase
$1,174 $2.61 p/Share
450 Added 2.28%
19,318 Common Stock
Mar 28 2024
BUY
Grant, award, or other acquisition
-
3,365 Added 15.14%
18,868 Common Stock
Mar 13 2024
BUY
Open market or private purchase
$7,362 $7.29 p/Share
1,010 Added 6.12%
15,503 Common Stock
Feb 27 2023
BUY
Grant, award, or other acquisition
$5,250 $5.25 p/Share
1,000 Added 6.45%
14,493 Common Stock
Jan 30 2023
BUY
Grant, award, or other acquisition
-
269,879 Added 50.0%
269,879 Common Stock

Also insider at

WINT
WINDTREE THERAPEUTICS INC Healthcare
SVP & CFO
JPH

John P. Hamill

SrVP/CFO/Prin Fin & Acct Ofcr
Warrington, PA

Track Institutional and Insider Activities on APRE

Follow Aprea Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APRE shares.

Notify only if

Insider Trading

Get notified when an Aprea Therapeutics, Inc. insider buys or sells APRE shares.

Notify only if

News

Receive news related to Aprea Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APRE